UBS O'Connor’s Claritev Corp CTEV Stock Holding History

UBS O'Connor’s Portfolio CTEV Stock Details CTEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-27,532	Closed	-$3.25M	–	414
2020 Q2	$3.25M	Buy	+27,532	New	+$11.1M	0.07%	187

Other funds holding CTEV

HFCIV

H&F Corporate Investors VIII San Francisco, California $63.5M AUM 20.79% 1-Year Est. Return

PIF

Public Investment Fund Al Aqiq District, Riyadh, Saudi Arabia $12B AUM 0.61% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SMR

SIH MPH Rollover New York $232M AUM 45.07% 1-Year Est. Return

CPV Partners Stamford, Connecticut $224M AUM 77.2% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS O'Connor's CTEV Position: Q4 2020 in Review

UBS O'Connor sold out of Claritev Corp (CTEV) in Q4 2020, closing a stake of 108,680 shares — an estimated $44.6M sold.

UBS O'Connor first reported a position in CTEV in Q2 2020 and held it in 2 quarters. The position peaked at $47.5M in Q2 2020. 93 funds tracked by Wall St. Rank hold CTEV as of Q4 2020.

UBS O'Connor reported no remaining Claritev Corp position as of Q4 2020 after selling out during the quarter.
UBS O'Connor sold 108,680 Claritev Corp shares in Q4 2020, an estimated $44.6M.
UBS O'Connor first reported a position in Claritev Corp in Q2 2020 and held it in 2 quarters.
UBS O'Connor's Claritev Corp position peaked at $47.5M in Q2 2020.
93 funds tracked by Wall St. Rank held Claritev Corp as of Q4 2020.

Based on UBS O'Connor's 13F filing for Q4 2020, filed 17 Feb 2021.